Wiegand H - Search Results

1

Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis.

Wagner J, von Matt P, Faller B, Cooke NG, Albert R, Sedrani R, Wiegand H, Jean C, Beerli C, Weckbecker G, Evenou JP, Zenke G, Cottens S. Wagner J, et al. Among authors: wiegand h. J Med Chem. 2011 Sep 8;54(17):6028-39. doi: 10.1021/jm200469u. Epub 2011 Aug 8. J Med Chem. 2011. PMID: 21797275

2

Pharmacokinetic investigation of a 14C-labelled beta 3/alpha tetrapeptide in rats.

Wiegand H, Wirz B, Schweitzer A, Gross G, Perez MI, Andres H, Kimmerlin T, Rueping M, Seebach D. Wiegand H, et al. Chem Biodivers. 2004 Nov;1(11):1812-28. doi: 10.1002/cbdv.200490136. Chem Biodivers. 2004. PMID: 17191818

3

The outstanding metabolic stability of a 14C-labeled beta-nonapeptide in rats--in vitro and in vivo pharmacokinetic studies.

Wiegand H, Wirz B, Schweitzer A, Camenisch GP, Rodriguez Perez MI, Gross G, Woessner R, Voges R, Arvidsson PI, Frackenpohl J, Seebach D. Wiegand H, et al. Biopharm Drug Dispos. 2002 Sep;23(6):251-62. doi: 10.1002/bdd.334. Biopharm Drug Dispos. 2002. PMID: 12214326

4

Biodistribution and plasma protein binding of zoledronic acid.

Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H. Weiss HM, et al. Among authors: wiegand h. Drug Metab Dispos. 2008 Oct;36(10):2043-9. doi: 10.1124/dmd.108.021071. Epub 2008 Jul 14. Drug Metab Dispos. 2008. PMID: 18625688

5

Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats.

Bruin GJ, Faller T, Wiegand H, Schweitzer A, Nick H, Schneider J, Boernsen KO, Waldmeier F. Bruin GJ, et al. Among authors: wiegand h. Drug Metab Dispos. 2008 Dec;36(12):2523-38. doi: 10.1124/dmd.108.022962. Epub 2008 Sep 5. Drug Metab Dispos. 2008. PMID: 18775980

6

[Epstein-Barr virus detection in oral hairy leukoplakia in AIDS patients, in leukoplakias and on normal tongue epithelia in HIV-1-negative patients].

Gross G, Wiegand H, Zentgraf H. Gross G, et al. Among authors: wiegand h. Z Hautkr. 1988 Jan 18;63(1):44-8. Z Hautkr. 1988. PMID: 2833041 German.

7

FTY720 pharmacokinetics in mild to moderate hepatic impairment.

Kovarik JM, Schmouder RL, Serra D, Wang Y, Wiegand H, Dilzer SC, Lasseter KC. Kovarik JM, et al. Among authors: wiegand h. J Clin Pharmacol. 2005 Apr;45(4):446-52. doi: 10.1177/0091270004274288. J Clin Pharmacol. 2005. PMID: 15778425

8

Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine.

Legay F, Gauron S, Deckert F, Gosset G, Pfaar U, Ravera C, Wiegand H, Schran H. Legay F, et al. Among authors: wiegand h. J Pharm Biomed Anal. 2002 Nov 7;30(4):897-911. doi: 10.1016/s0731-7085(02)00218-2. J Pharm Biomed Anal. 2002. PMID: 12408879

9

Fatal Hodgkin and non-Hodgkin lymphoma associated with persistent Epstein-Barr virus in four brothers.

Donhuijsen-Ant R, Abken H, Bornkamm G, Donhuijsen K, Grosse-Wilde H, Neumann-Haefelin D, Westerhausen M, Wiegand H. Donhuijsen-Ant R, et al. Among authors: wiegand h. Ann Intern Med. 1988 Dec 15;109(12):946-52. doi: 10.7326/0003-4819-109-12-946. Ann Intern Med. 1988. PMID: 2848435

10

Epstein-Barr virus infection rapidly progressing to monoclonal lymphoproliferative disease in a child with selective immunodeficiency.

Schuster V, Kreth HW, Müller-Hermelink HK, Huppertz HI, Feller AC, Neumann-Haefelin D, Wiegand H, Müller-Lantzsch N. Schuster V, et al. Among authors: wiegand h. Eur J Pediatr. 1990 Nov;150(1):48-53. doi: 10.1007/BF01959480. Eur J Pediatr. 1990. PMID: 1964121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page